Literature DB >> 21348852

Targeting focal adhesion kinase in cancer-part I.

Vita M Golubovskaya.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21348852     DOI: 10.2174/187152010794728693

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


× No keyword cloud information.
  6 in total

Review 1.  Targeting the p53 pathway.

Authors:  Vita M Golubovskaya; William G Cance
Journal:  Surg Oncol Clin N Am       Date:  2013-07-30       Impact factor: 3.495

Review 2.  FAK and Nanog cross talk with p53 in cancer stem cells.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

Review 3.  NANOG: a promising target for digestive malignant tumors.

Authors:  Ai-Xi Sun; Chang-Jiang Liu; Zi-Qin Sun; Zhi Wei
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.

Authors:  M B Meads; B Fang; L Mathews; J Gemmer; L Nong; I Rosado-Lopez; T Nguyen; J E Ring; W Matsui; A R MacLeod; J A Pachter; L A Hazlehurst; J M Koomen; K H Shain
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

5.  MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells.

Authors:  Vita M Golubovskaya; Brittany Sumbler; Baotran Ho; Michael Yemma; William G Cance
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

Review 6.  Influenza Virus Infections and Cellular Kinases.

Authors:  Robert Meineke; Guus F Rimmelzwaan; Husni Elbahesh
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.